Essential Hypertension References

Below you can find the list of references for this paper.

  1. Geller DS. New Developments in the Genetics of Hypertension: What Should Clinicians Know? Current cardiology reports 2015; 17(12): 122.
  2. Harrap SB, Charchar FJ. Genetics of blood pressure: time to curate the collection. Journal of hypertension 2017; 35(7): 1360-2.
  3. Brunner HR, Sealey JE, Laragh JH. Renin as a risk factor in essential hypertension: more evidence. The American journal of medicine 1973; 55(3): 295-302.
  4. Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. Journal of clinical hypertension (Greenwich, Conn) 2006; 8(8): 596-9.
  5. Cicala MV, Mantero F. Hypertension in Cushing’s syndrome: from pathogenesis to treatment. Neuroendocrinology 2010; 92 Suppl 1: 44-9.
  6. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. The Journal of physiology 1902; 28(3): 220-31.
  7. Sivertsson R, Hansson L. Effects of blood pressure reduction on the structural vascular abnormality in skin and muscle vascular beds in human essential hypertension. Clinical science and molecular medicine Supplement 1976; 3: 77s-9s.
  8. Hansson L, Sivertsson R. Regression of structural cardiovascular changes by antihypertensive therapy. Hypertension (Dallas, Tex : 1979) 1984; 6(6 Pt 2): III147-9.
  9. Zuber SM, Kantorovich V, Pacak K. Hypertension in pheochromocytoma: characteristics and treatment. Endocrinology and metabolism clinics of North America 2011; 40(2): 295-311, vii.
  10. Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clinical science (London, England : 1979) 1997; 92(5): 473-9.
  11. Grossman E, Messerli FH. Drug-induced hypertension: an unappreciated cause of secondary hypertension. The American journal of medicine 2012; 125(1): 14-22.
  12. Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962; 51(2): 224-32.
  13. Conn JW, Cohen EL, Rovner DR. Landmark article Oct 19, 1964: Suppression of plasma renin activity in primary aldosteronism. Distinguishing primary from secondary aldosteronism in hypertensive disease. By Jerome W. Conn, Edwin L. Cohen and David R. Rovner. Jama 1985; 253(4): 558-66.
  14. Gottam N, Nanjundappa A, Dieter RS. Renal artery stenosis: pathophysiology and treatment. Expert review of cardiovascular therapy 2009; 7(11): 1413-20.
  15. Cooper JN, Buchanich JM, Youk A, et al. Reductions in arterial stiffness with weight loss in overweight and obese young adults: potential mechanisms. Atherosclerosis 2012; 223(2): 485-90.
  16. LK. D. Possible role of salt intake in the development of essential hypertension. In: Cottier P, Bock KD, eds. Essential hypertension—an international symposium. Berlin: Springer-Verlag; ; 1960: 53–65.
  17. Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ (Clinical research ed) 1996; 312(7041): 1249-53.
  18. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ (Clinical research ed) 1988; 297(6644): 319-28.
  19. Loria CM, Obarzanek E, Ernst ND. Choose and prepare foods with less salt: dietary advice for all Americans. The Journal of nutrition 2001; 131(2s-1): 536s-51s.
  20. Geiringer E. The Gerontological Aspects of Atheroma: An Approach to a Pathology of Senescence. British Journal of Social Medicine 1948; 2: 132-8.
  21. Moon HD. Coronary arteries in fetuses, infants, and juveniles. Circulation 1957; 16(2): 263-7.
  22. Enos WF, Holmes RH, Beyer J. Landmark article, July 18, 1953: Coronary disease among United States soldiers killed in action in Korea. Preliminary report. By William F. Enos, Robert H. Holmes and James Beyer. Jama 1986; 256(20): 2859-62.
  23. Tedla YG, Gepner AD, Vaidya D, et al. Association between long-term blood pressure control and ten-year progression in carotid arterial stiffness among hypertensive individuals: the multiethnic study of atherosclerosis. Journal of hypertension 2017; 35(4): 862-9.
  24. Gepner AD, Tedla Y, Colangelo LA, et al. Progression of Carotid Arterial Stiffness With Treatment of Hypertension Over 10 Years: The Multi-Ethnic Study of Atherosclerosis. Hypertension (Dallas, Tex : 1979) 2017; 69(1): 87-95.
  25. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet (London, England) 2001; 358(9291): 1400-4.
  26. Wilens SL. The Postmortem Elasticity of the Adult Human Aorta. Its Relation to Age and to the Distribution of Intimal Atheromas. The American journal of pathology 1937; 13(5): 811-34.3.
  27. Femia R, Kozakova M, Nannipieri M, et al. Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression. Arteriosclerosis, thrombosis, and vascular biology 2007; 27(10): 2244-9.
  28. Pickering GW. The Circulation in Arterial Hypertension-I. British medical journal 1943; 2(4304): 1-4.
  29. Pickering GW. The Circulation in Arterial Hypertension. British medical journal 1943; 2(4305): 31-4.
  30. Vaughan ED, Laragh JH, Gavras I, et al. Volume factor in low and normal renin essential hypertension: Treatment with either spironolactone or chlorthalidone. The American journal of cardiology 1973; 32(4): 523-32.
  31. Mroczek WJ, Finnerty FA, Jr., Catt KJ. Low-renin hypertension. The New England journal of medicine 1973; 288(20): 1077-8.
  32. Buhler FR, Laragh JH, Sealey JE, Brunner HR. Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Studies using a rapid assay of plasma aldosterone. The American journal of cardiology 1973; 32(4): 554-61.
  33. Moore TJ, Williams GH, Dluhy RG, Bavli SZ, Himathongkam T, Greenfield M. Altered renin-angiotensin-aldosterone relationships in normal renin essential hypertension. Circ Res 1977; 41(2): 167-71.
  34. Laragh JH, Letcher RL, Pickering TG. Renin profiling for diagnosis and treatment of hypertension. Jama 1979; 241(2): 151-6.
  35. Laragh JH. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. The American journal of medicine 1973; 55(3): 261-74.
  36. Kotchen TA, Guthrie GP, Jr., Cottrill CM, McKean HE, Kotchen JM. Low renin-aldosterone in “prehypertensive” young adults. The Journal of clinical endocrinology and metabolism 1982; 54(4): 808-14.
  37. Noth RH, Lassman MN, Tan SY, Fernandez-Cruz A, Jr., Mulrow PJ. Age and the renin-aldosterone system. Arch Intern Med 1977; 137(10): 1414-7.
  38. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. American journal of hypertension 1989; 2(3 Pt 2): 140s-6s.
  39. Julius S, Nesbitt S. Sympathetic overactivity in hypertension. A moving target. American journal of hypertension 1996; 9(11): 113s-20s.
  40. Esler M, Rumantir M, Kaye D, Lambert G. The sympathetic neurobiology of essential hypertension: disparate influences of obesity, stress, and noradrenaline transporter dysfunction? American journal of hypertension 2001; 14(6 Pt 2): 139s-46s.
  41. Schobel HP, Heusser K, Schmieder RE, Veelken R, Fischer T, Luft FC. Evidence against elevated sympathetic vasoconstrictor activity in borderline hypertension. Journal of the American Society of Nephrology : JASN 1998; 9(9): 1581-7.
  42. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. American journal of hypertension 1989; 2(3 Pt 2): 125s-32s.
  43. Novak V, Lipsitz LA. Ageing and the Autonomic Nervous System. In: Robertson D, ed. Primer on the Autonomic Nervous System. Second ed. San Diego, California: Elsevier; 2004.
  44. Safar ME, Blacher J, Protogerou A, Achimastos A. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification. Journal of hypertension 2008; 26(1): 130-7.
  45. Virchow R. Phlogose und Thrombose im Gefasssystem. Gesammelte Abhandlungen zur Wissenschaftlichen Medicin. . Frankfurt: Meidinger Sohn and Co; 1856.
  46. Pickering TG. Isolated diastolic hypertension. Journal of clinical hypertension (Greenwich, Conn) 2003; 5(6): 411-3.
  47. Hozawa A, Ohkubo T, Nagai K, et al. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: the Ohasama study. Arch Intern Med 2000; 160(21): 3301-6.
  48. Strandberg TE, Salomaa VV, Vanhanen HT, Pitkala K, Miettinen TA. Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years. Journal of hypertension 2002; 20(3): 399-404.